Document is current
Any future updates will be listed below
-
Authors
Chan, Henry L. Y.
Hu, Yao
Malinowsky, Katharina
Madin, Kairat
Kroeniger, Konstantin
Hou, Jinlin
Sharma, Ashish
-
Funding
Funding for this research was provided by:
Roche Diagnostics
- License Information
-
More Information
Article History
Received: 21 August 2024
Accepted: 18 November 2024
First Online: 22 November 2024
Declarations
:
: HLYC reports consultancy fees from Arbutus Biopharma, Gilead Sciences, Glaxo-Smith-Kline, Roche, Vir Biotechnology, Aligos Therapeutics, Vaccitech, and Virion Therapeutics; and speaker’s bureau participation for Echosens, Gilead Sciences, Roche, and Viatris. YH has no conflicts of interest to declare. KMad, KK, and AS are employees of Roche Diagnostics International AG. KMal is an employee of Microcoat Biotechnologie, contracted by Roche Diagnostics. JH reports speaker’s bureau participation for Glaxo-Smith-Kline, Gilead Sciences, and Roche Diagnostics; has received grant/research support from Gilead Sciences and BMS; and has served on an advisory committee or review panel for Aligos, Assembly, Glaxo-Smith-Kline, Gilead Sciences, Johnson Pharmaceutica, and Roche.
